France has recalled all remaining stocks of Tavneos, a drug used to treat rare autoimmune diseases, after European regulators withdrew its marketing authorization. The decision follows concerns about the drug’s clinical trial data and reports of serious liver injuries, including deaths. France orders Tavneos recall France’s medicines safety agency, the ANSM, said Vifor France would […]
The post France pulls rare disease drug Tavneos after deaths appeared first on Insider Paper.
